Expert in Pharmaceuticals, Drug Delivery, OTC, and Rx products
Expert's strengths include:
- Strong knowledge of the Specialty Rx and OTC marketplace, Rx to OTC switch process, and DSHEA/nutritional marketplace.
- The ability to evaluate new product opportunities, determine strengths, key gaps and opportunities for improvement. Knowledge of Technical. Regulatory, Commercial and Legal areas critical for successful new product development and optimization process.
- Strong business (analytical and strategic) skills.
- Strong background in Intellectual Property assessment.
- Knowledge of Drug Delivery and pharmaceutical product formulation technologies including oral, sustained release, transdermal/topical, inhalation, and nasal routes.
His career spans over 35 years.
Expert has consulted independently in the pharmaceutical industry since 2008.
Expert may consult nationally and internationally, and is also local to the following cities: New York, New York - Newark, New Jersey - Jersey City, New Jersey - Paterson, New Jersey - Elizabeth, New Jersey - Trenton, New Jersey - Philadelphia, Pennsylvania - Allentown, Pennsylvania - Reading, Pennsylvania - Baltimore, Maryland
|Year: 2005||Degree: MBA||Subject: Finance||Institution: Haub School of Business, St. Joseph's University|
|Year: 1978||Degree: Ph.D||Subject: Polymer Science and Engineering||Institution: University of Massachusetts|
|Year: 1977||Degree: MS||Subject: Polymer Science and Engineering||Institution: University of Massachusetts|
|Year: 1974||Degree: BS||Subject: Macromolecular Science||Institution: Case Western Reserve University|
|Years: 2008 to Present||Employer: Undisclosed||Title: Consultant||Department:||Responsibilities: Expert lends his insight and experience to pharmaceutical companies and investment companies. He provides identification and analysis of specific drug delivery technologies and companies, development of corporate strategy, and identification of business development leads and contacts.|
|Years: 1998 to 2008||Employer: Johnson & Johnson||Title: Director of Science and Technology, Business Development||Department: McNeil Consumer Healthcare and McNeil Specialty Pharmaceuticals||Responsibilities: Expert was responsible for the identification, evaluation, and in-licensing of new product opportunities, primarily in the field of Rx pharmaceuticals. Specific therapeutic areas included ADHD/ADD, analgesics (oral and topical), migraine, CNS, antibiotics, cystic fibrosis, hypnotics/sleep aids, gastrointestinal, allergy, asthma and other respiratory, specialty oncology, vaccines, pediatric, sexual dysfunction, and lifestyle. He conducted extensive evaluation of new technologies in drug delivery, pro-drugs and other areas. He also established initial conduct with outside companies as well as led contacts throughout deal process.|
|Years: 1984 to 1998||Employer: Johnson & Johnson||Title: Manager, Drug Delivery Research||Department: McNeil Consumer Products||Responsibilities: Expert managed a group of 15 people including five research scientists developing new drug delivery systems for oral, transdermal/topical, nasal and inhalation pharmaceutical products. The group included pharmacists, analytical chemists and chemical engineers.|
|Years: 1980 to 1984||Employer: B. F. Goodrich||Title: Advanced R&D Chemist||Department:||Responsibilities: Expert supervised a laboratory for the study of mechanical and thermal properties of polymers.|
|Years: 1978 to 1980||Employer: Centre d'Etudes Nucleaires (Grenoble, France)||Title: Postdoctoral Research||Department:||Responsibilities: Expert conducted postdoctoral research on ion-containing polymers.|
|Chair, Johnson & Johnson Drug Delivery Subcommittee, 1993-1996|
|Awards / Recognition|
|Philip Hoffman Award for Excellence in R&D, 3/92.
Johnson & Johnson Achievement Award 1990, 1992, 2004
Member, Beta Gamma Sigma, International Honor Society for collegiate schools of business
|Publications and Patents Summary|
|Expert has 8 refereed scientific publications. He is an Inventor on 15 U.S. patents covering the use of polymer blend systems to control drug release from micro-particulates, prevent drug/drug incompatibilities, and novel drug delivery systems.|